Abbott India Ltd., a prominent multinational pharmaceutical company, operates with a manufacturing facility in Goa and multiple third-party manufacturers across India. The company markets a diverse range of products through independent distributors, focusing on therapeutic areas including Women's Health, Gastroenterology, CNS, Metabolics, and Vaccines. Notable global products are Brufen, Prothiaden, and Thyronorm. Their business is structured into four divisions: Primary Care, Specialty Care-Metabolics and Urology, Specialty Care-Neuroscience, and Hospital Care. Abbott India has a rich history of product innovation and expansion, launching numerous products annually, such as Arachitol Nano and Florachamp, to meet increasing healthcare demands.
Founded in 1944 as Boots Pure Drug Company, Abbott India underwent several name changes before adopting its current name in 2002. The company has actively expanded its portfolio, enhanced capacities, and formed strategic partnerships to bolster its market presence in high-growth therapeutic areas. Recent years have seen continued product diversification, including the launch of unique offerings like Arachitol Gummies and the expansion of its vaccine portfolio. Abbott India has consistently leveraged digital technology to engage healthcare professionals and patients, maintaining a strong focus on innovation and therapy leadership in the pharmaceutical industry.
